[ { "@graph" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#pubinfo" } ] } ], "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#Head" }, { "@graph" : [ { "@id" : "http://resource.belframework.org/belframework/1.0/namespace/selventa-named-human-complexes/AP-1%20Complex", "@type" : [ "http://amigo.geneontology.org/amigo/term/GO:0043234" ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#_1", "@type" : [ "http://amigo.geneontology.org/amigo/term/GO:0042789" ], "http://semanticscience.org/resource/SIO_000139" : [ { "@id" : "http://resource.belframework.org/belframework/1.0/namespace/selventa-named-human-complexes/AP-1%20Complex" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#_2", "@type" : [ "http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_33697" ], "http://purl.obolibrary.org/obo/RO_0002204" : [ { "@id" : "http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=4421" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#_3", "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://purl.obolibrary.org/obo/BFO_0000066" : [ { "@id" : "http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#_2" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "http://www.selventa.com/vocabulary/directlyDecreases" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#_1" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#assertion", "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "tscript(complex(NCH:\"AP-1 Complex\")) =| r(HGNC:GNRHR)" } ] } ], "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#assertion" }, { "@graph" : [ { "@id" : "http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel", "http://purl.org/dc/elements/1.1/description" : [ { "@value" : "Approximately 61,000 statements." } ], "http://purl.org/dc/elements/1.1/rights" : [ { "@value" : "Copyright (c) 2011-2012, Selventa. All rights reserved." } ], "http://purl.org/dc/elements/1.1/title" : [ { "@value" : "BEL Framework Large Corpus Document" } ], "http://purl.org/pav/authoredBy" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#_5" } ], "http://purl.org/pav/version" : [ { "@value" : "1.4" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#_4", "http://www.w3.org/ns/prov#value" : [ { "@value" : "2 potential AP-1 binding sites located at positions -1000 to -994 and -943 to -937 was identified in the 248-bp fragment of the gonadotropin releasing hormone receptor (Gnrhr). A decrease in human GnRHR promoter activity was observed after GnRHa (GnRH agonists) treatment. GnRHa- and TPA-mediated decrease in the human GnRHR promoter activity was reversed by a specific protein kinase C inhibitor. These findings indicate that the activation of the PKC pathway is important in regulating the human GnRHR gene expression. EMSA studies with alphaT3-1 cells transfected with the Gnrhr reporter construct using anti-c-jun antibody demonstrated the binding of c-jun to the AP-1 binding site of the Gnrhr promoter. It was also demonstrated that mutation of the AP-1 binding site at -1000 to -994 abolished the GnRHa (GnRH agonists) induced inhibition. Thus, AP-1-binding site located at -1000 to -994 of the human GnRHR5'-flanking region has been identified to be involved in mediating the down-regulatory effect." } ], "http://www.w3.org/ns/prov#wasQuotedFrom" : [ { "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/11014215" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#_5", "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Selventa" } ] }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#assertion", "http://www.w3.org/ns/prov#hadPrimarySource" : [ { "@id" : "http://www.ncbi.nlm.nih.gov/pubmed/11014215" } ], "http://www.w3.org/ns/prov#wasDerivedFrom" : [ { "@id" : "http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel" }, { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#_4" } ] } ], "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#provenance" }, { "@graph" : [ { "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ", "http://purl.org/dc/terms/created" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2014-07-03T14:29:52.540+02:00" } ], "http://purl.org/pav/createdBy" : [ { "@id" : "http://orcid.org/0000-0001-6818-334X" }, { "@id" : "http://orcid.org/0000-0002-1267-0234" } ] } ], "@id" : "http://www.tkuhn.ch/bel2nanopub/RANDJhyplvE-PkRvo-qvG_vYospabFy-O-q9Hp2U4jJTQ#pubinfo" } ]